胞外体的全球市场 - 市场规模，占有率，成长分析:各用途，各产品类型，各终端用户，工作流程，各生物分子类型 - 产业预测(2022年～2028年)

Global Exosomes Market Size, Share, Growth Analysis, By Application, By Product, By End-User, By Workflow, By Biomolecule Type - Industry Forecast 2022-2028

出版日期: 2023年04月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球胞外体的市场规模预测将从2022年的1,122亿5,000万美元到2030年达到8兆7,939亿5,000万美元，在预测期间(2023年～2030年)时预计将以年复合成长率32.75％的速度成长。研究活动的活跃，技术的进步，生物科技企业和製药企业的投资增加，推动了该市场的成长。

本报告提供全球胞外体市场相关调查分析，提供市场动态及预测，市场区隔分析，企业简介等资讯。

The global exosomes market refers to the commercial activities related to the isolation, purification, and characterization of exosomes, which are extracellular vesicles secreted by most cell types. Exosomes play important roles in intercellular communication, and their diagnostic and therapeutic potential is being explored in various fields, including cancer, regenerative medicine, and drug delivery. The market is expected to grow due to increasing research activities, technological advancements, and rising investments by biotechnology and pharmaceutical companies. However, challenges such as standardization, scalability, and regulatory issues need to be addressed for the successful translation of exosome-based products into clinical practice.

Top-down and bottom-up approaches were used to estimate and validate the size of Exosomes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The Global Exosomes Market is segmented based on the Application, Product, End-User, and region. Based on the Application, the Market is segmented into diagnostic and therapeutic applications. Based on the Product, the Market is segmented into instruments, reagents, and software. Based on the End-User, the Market is segmented as cancer institute, hospitals, diagnostic centers, and others (medical universities and not-for-profit organizations). Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

The development of novel drugs and medical devices involves substantial investments from pharmaceutical, biopharmaceutical, and medical device companies. These businesses allocate significant resources to research and development (R&D) in order to offer innovative and top-quality products to the market. As per current patterns, major players in the pharmaceutical industry are boosting their R&D efficiency by making substantial and enduring investments in R&D, as well as by collaborating on joint R&D ventures. This strategy helps these companies to remain at the forefront of the industry and continue to bring new and improved products to consumers.

Restrain

The field of exosome research is still in its early stages, lacking established standards. As a result, professionals readily adopt new techniques and processes available on the market. In addition to the challenges of exosome creation, scientists face obstacles in their research, development, and manufacturing. Recently, exosomes derived from MSCs have garnered attention due to their function as intercellular messengers. These unique properties make them attractive for scientific applications such as cancer diagnostics, vaccine development, gene therapy, cell treatment, and drug administration. Therefore, to successfully harvest exosomes and establish industry-leading standards for their purification and characterization, developers of MSC-exosome treatments must adapt their stem cell-free therapy process to meet the demands of exosome manufacturing.

Trend

Exosomes have emerged as a promising treatment approach for various ailments, including COVID-19. These tiny vesicles have been utilized in the medical field to transport therapeutic payloads, circumventing issues like immune rejection and cellular harm. As a cell-free alternative, they offer a potential solution for treating diverse diseases and promoting tissue repair. Specifically, exosomal therapy targeted towards respiratory viral infections, such as SARS-CoV-2, can be developed using stem cell-derived exosomes, which possess favorable anti-inflammatory and regenerative traits inherited from their parent cells.